期刊文献+

阿尔茨海默病相关核心生物标志物研究进展 被引量:8

Research progress of core biomarkers related to Alzheimer's disease
原文传递
导出
摘要 阿尔茨海默病作为近年来患病率最高的中老年疾病之一,以导致患者认知功能障碍、记忆力减退、性格改变为主要表现,其神经病理学特点为老年斑和神经元内神经原纤维缠结等。此病起病隐袭,临床症状出现前即有相应的生物学标记物改变;而易检、高敏感性及高特异性的有效生物学标记物有助于疾病早期诊断和早期治疗,意义重大。通过综述目前较为成熟的阿尔茨海默病相关核心生物学标记物,以讨论其临床及科研应用价值并展望未来的发展趋势。 As one of the most popular diseases affecting the old population in recent years, Alzheimer's disease manifests its clinical symptoms as cognitive function impairment, memory loss and personality alternation. The neuropathology characteristics include senile plaques and neurofibrillary tangles. As the onset is not evident, the biomarker changes precede clinical symptoms. A convenient biomarker with high sensitivity and specificity would help the early diagnosis and treatment of disease, which is of great value. We review the core and mature biomarkers related to Alzheimer's disease, discuss the clinical and scientific value for application, and look forward to its development in the future.
作者 陈逸 张宝荣
出处 《生命科学》 CSCD 2014年第1期2-8,共7页 Chinese Bulletin of Life Sciences
基金 国家重点基础研究发展计划("973"项目)(2013CB530900)
关键词 阿尔茨海默病 生物学标记物 Β淀粉样蛋白 TAU蛋白 Alzheimer's disease biomarker tau
  • 相关文献

参考文献1

二级参考文献9

  • 1Etsuro M, Mikio S, Koji A, et al. Vascular amyloidosis in neurodegenerative condition[J]. Drugs News Perspect, 2002,15:439-444.
  • 2Kuo YM, Emmerling MR, Lapert HC, et al. High levels of circulating A beta42 are sequestered by plasma proteins in AD[J].Biochem Biophys Res Commun, 1999,257: 787-794.
  • 3刘世杰 王建枝.Tau蛋白的结构、功能和异常修饰与阿尔茨海默病的关系[M].见:盛树力.老年性痴呆:发病机理与药物研究[M].北京:科学技术文献出版社,2003.107-119.
  • 4Gong CX, Lidsky T, Wegiel J, et al. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain implications for neurofibrillary degeneration in Alzheimer's disease[J]. J Biochem, 2000,275(8): 5535-5544.
  • 5Thurston VC, Zinkowski RP, Binder LI. Tau as a nucleolar protein in human nonneural cell in vitro and in vivo[J]. Chromosoma, 1996,105:20-30.
  • 6Martin I, Mari B, Eirikur B, et al. Tau immunoreactivity detected in human plasma, but no obvious increase in dementia[J]. Dement Geriatr Cogn Disord, 1999,10:442-445.
  • 7Hampel H, Goernitz A, Buerger K. Advances in the development of biomarkers for Alzheimer disease: from CSF total tau and Aβ1-42 ptroteins to phosphorylated tau protein[J]. Brain Res Bull, 2003,61(3): 243-253.
  • 8Hampel H, Buerger K, Zinkowski R, et al. Measurement of phosphorylated tau epitopes differential diagnosis of Alzheimer disease comparative cerebrospinal fluid study[J], Arch Gen Psychiatry, 2004,61(1): 95-102.
  • 9Andreasen N, Sjogren M, Blennow K. CSF marker for Alzheimer disease: total tau, phospho-tau and Aβ42[J]. World J Biol Psychiatry, 2003,4(4): 147-155.

共引文献12

同被引文献78

引证文献8

二级引证文献119

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部